Target intelligence / Profile preview

Potassium voltage-gated channel subfamily Q member 1 (KCNQ1) and Potassium voltage-gated channel subfamily E regulatory subunit 1 (KCNE1) complex (IKs)

Target
IKs
Molecular classification
Ion channel, Voltage-gated potassium channel, Heteromeric protein complex
01

Overview

The slow delayed rectifier potassium current (IKs) is a fundamental component of the cardiac action potential repolarization process, particularly significant during sympathetic stimulation or increased heart rates [4]. It is mediated by a protein complex consisting of the pore-forming alpha subunit KCNQ1 (Kv7.1) and the regulatory beta subunit KCNE1 (minK) [1, 2]. In rabbit ventricular myocytes, as in humans, IKs provides a critical 'repolarization reserve' that helps maintain electrical stability in the heart under stress [4, 5]. Mutations in the genes encoding these subunits are linked to hereditary Long QT syndromes, specifically LQT1 and LQT5, which predispose individuals to life-threatening arrhythmias [5]. Pharmacological modulation of IKs is a target for anti-arrhythmic therapy, although excessive blockade can lead to pathological prolongation of the QT interval and increased risk of sudden cardiac death [4]. The rabbit model is frequently used in cardiovascular research because its IKs current properties closely mimic those of human ventricular myocytes [4].

Other names
Slow delayed rectifier potassium currentIKsKv7.1/minK complexKCNQ1/KCNE1KVLQT1/minK
02

Mechanism of action

Inhibition of the KCNQ1/KCNE1 channel complex reduces the outward potassium current during the plateau phase of the cardiac action potential, thereby prolonging the repolarization phase and increasing the action potential duration [4, 5].

03

Biological functions

Cardiac repolarizationRegulation of action potential durationPotassium ion transportRepolarization reserve maintenance
04

Disease associations

Long QT syndromeShort QT syndromeAtrial fibrillationCardiac arrhythmiaSudden cardiac death
05

Safety considerations

Risk of Torsades de PointesDrug-induced Long QT syndromeVentricular tachycardiaPro-arrhythmic potential
06

Interacting drugs

Chromanol 293B

5 more in the full profile.

07

Biomarkers

QT intervalCorrected QT interval (QTc)Action potential duration (APD)

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily Q member 1 (KCNQ1) and Potassium voltage-gated channel subfamily E regulatory subunit 1 (KCNE1) complex (IKs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily Q member 1 (KCNQ1) and Potassium voltage-gated channel subfamily E regulatory subunit 1 (KCNE1) complex (IKs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call